Tom is a Translational Fellow and during his fellowship hopes to take a critical step forward in Pneumocystis research, contributing to breakthroughs in diagnosis and therapy.
Tom's research harnesses the power of human induced pluripotent stem cells (iPSCs) coupled with genetic risk to provide complex in vitro models of microglia and organoids that enable him to study the phenotypic consequences of defined risk. He uses a multidisciplinary approach to identify novel targets and pathways that can be therapeutically targeted using strategies including drug repurposing that have the potential to provide rapid translation of findings to the clinic.